The results indicate that ROS produced following administration of isoflurane contribute to protection against myocardial infarction in vivo.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: